Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Ji, Qingwei ^a,b   Zeng, Qiutang ^c   Huang, Ying ^b   Shi, Ying ^b   Lin, Yingzhong ^b   Lu, Zhengde ^b   Meng, Kai ^c   Wu, Bangwei ^c   Yu, Kunwu ^c   Chai, Meng ^a   Liu, Yuyang ^a   Zhou, Yujie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 37; UNCLASSIFIED DRUG; BRAIN NATRIURETIC PEPTIDE; IL37 PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN-18 BINDING PROTEIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); SIGNAL PEPTIDE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD; CYTOLOGY; DOPPLER ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR FUNCTION, LEFT;

EID: 84897002449     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/165742     Document Type: Article

References (46)

1. Nold M. F., Nold-Petry C. A., Zepp J. A., Palmer B. E., Bufler P., Dinarello C. A., IL-37 is a fundamental inhibitor of innate immunity. Nature Immunology 2010 11 11 1014 1022 2-s2.0-77958149102 10.1038/ni.1944
2. Boraschi D., Lucchesi D., Hainzl S., Leitner M., Maier E., Mangelberger D., Oostingh G. J., Pfaller T., Pixner C., Posselt G., Italiani P., Nold M. F., Nold-Petry C. A., Bufler P., Dinarello C. A., IL-37: a new anti-inflammatory cytokine of the IL-1 family. European Cytokine Network 2011 22 3 127 147 2-s2.0-83055163376 10.1684/ecn.2011.0288
3. Pan G., Risser P., Mao W., Baldwin D. T., Zhong A. W., Filvaroff E., Yansura D., Lewis L., Eigenbrot C., Henzel W. J., Vandlen R., IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 2001 13 1 1 7 2-s2.0-0035819245 10.1006/cyto.2000.0799 (Pubitemid 32579216)
4. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., Asano M., Moriwaki H., Seishima M., Lack of interleukin-1 β decreases the severity of atherosclerosis in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 656 660 2-s2.0-0037388984 10.1161/01.ATV.0000064374. 15232.C3 (Pubitemid 36438080)
5. Merhi-Soussi F., Kwak B. R., Magne D., Chadjichristos C., Berti M., Pelli G., James R. W., MacH F., Gabay C., Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovascular Research 2005 66 3 583 593 2-s2.0-19444370696 10.1016/j.cardiores.2005.01.008 (Pubitemid 40725770)
6. de Nooijer R., von der Thüsen J. H., Verkleij C. J., Kuiper J., Jukema J. W., van der Wall E. E., van Berkel J. C., Biessen E. A., Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 12 2313 2319 2-s2.0-10644233212 10.1161/01.ATV.0000147126.99529.0a (Pubitemid 39658035)
7. Mallat Z., Henry P., Fressonnet R., Alouani S., Scoazec A., Beaufils P., Chvatchko Y., Tedgui A., Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 2002 88 5 467 469 2-s2.0-0036841649 10.1136/heart.88.5.467 (Pubitemid 35221955)
8. Oboki K., Ohno T., Kajiwara N., Arae K., Morita H., Ishii A., Nambu A., Abe T., Kiyonari H., Matsumoto K., Sudo K., Okumura K., Saito H., Nakae S., IL-33 is a crucial amplifier of innate rather than acquired immunity. Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 18581 18586 2-s2.0-78649821588 10.1073/pnas.1003059107
9. Wasserman A., Ben-Shoshan J., Entin-Meer M., Maysel-Auslender S., Guzner-Gur H., Keren G., Interleukin-33 augments Treg cell levels: a flaw mechanism in atherosclerosis. The Israel Medical Association Journal 2012 14 10 620 623
10. Miller A. M., Xu D., Asquith D. L., Denby L., Li Y., Sattar N., Baker A. H., McInnes I. B., Liew F. Y., IL-33 reduces the development of atherosclerosis. The Journal of Experimental Medicine 2008 205 2 339 346 2-s2.0-39549100797 10.1084/jem.20071868 (Pubitemid 351281600)
11. Sharma S., Kulk N., Nold M. F., Gräf R., Kim S.-H., Reinhardt D., Dinarello C. A., Bufler P., The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. The Journal of Immunology 2008 180 8 5477 5482 2-s2.0-45949111754
12. McNamee E. N., Masterson J. C., Jedlicka P., McManus M., Grenz A., Collins C. B., Nold M. F., Nold-Petry C., Bufler P., Dinarello C. A., Rivera-Nieves J., Interleukin 37 expression protects mice from colitis. Proceedings of the National Academy of Sciences of the United States of America 2011 108 40 16711 16716 2-s2.0-80053624991 10.1073/pnas.1111982108
13. Sakai N., van Sweringen H. L., Belizaire R. M., Quillin R. C., Schuster R., Blanchard J., Burns J. M., Tevar A. D., Edwards M. J., Lentsch A. B., Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. Journal of Gastroenterology and Hepatology 2012 27 10 1609 1616 10.1111/j.1440-1746.2012.07187.x
14. Li C., Zhao P., Sun X., Che Y., Jiang Y., Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with guillain-barre syndrome. Mediators of Inflammation 2013 2013 9 639712 10.1155/2013/639712
15. Li C., Ji H., Cai Y., Ayana D. A., Lv P., Liu M., Jiang Y., Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. Journal of Interferon & Cytokine Research 2013 33 10 612 618 10.1089/jir.2013.0001
16. Song L., Qiu F., Fan Y., Ding F., Liu H., Shu Q., Liu W., Li X., Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. Journal of Clinical Immunology 2013 33 1 111 117 10.1007/s10875-012-9791-z
17. Ji Q.-W., Guo M., Zheng J.-S., Mao X.-B., Peng Y.-D., Li S.-N., Liang Z.-S., Dai Z.-Y., Mao Y., Zeng Q.-T., Downregulation of T helper cell type 3 in patients with acute coronary syndrome. Archives of Medical Research 2009 40 4 285 293 2-s2.0-67650091225 10.1016/j.arcmed.2009.04.002
18. Lin Y., Huang Y., Lu Z., Luo C., Shi Y., Zeng Q., Cao Y., Liu L., Wang X., Ji Q., Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases. PloS ONE 2012 7 12 e52490 10.1371/journal.pone.0052490
19. Gensini G. G., A more meaningful scoring system for determining the severity of coronary heart disease. The American Journal of Cardiology 1983 51 3 606 2-s2.0-0020701346 10.1016/S0002-9149(83)80105-2 (Pubitemid 13187192)
20. Kragelund C., Grønning B., Køber L., Hildebrandt P., Steffensen R., N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. The New England Journal of Medicine 2005 352 7 666 675 2-s2.0-13744259846 10.1056/NEJMoa042330 (Pubitemid 40239214)
21. Weber M., Bazzino O., Estrada J. L. N., Fuselli J. J., Botto F., de Arenaza D. P., Möllmann H., Nef H. N., Elsässer A., Hamm C. W., N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Journal of the American College of Cardiology 2008 51 12 1188 1195 2-s2.0-40749149168 10.1016/j.jacc.2007.11.054 (Pubitemid 351382099)
22. Narins C. R., Lin D. A., Burton P. B., Jin Z.-G., Berk B. C., Interleukin-18 and interleukin-18 binding protein levels before and after percutaneous coronary intervention in patients with and without recent myocardial infarction. The American Journal of Cardiology 2004 94 10 1285 1287 2-s2.0-7944232612 10.1016/j.amjcard.2004.07.114 (Pubitemid 39469950)
23. Maier W., Altwegg L. A., Corti R., Gay S., Hersberger M., Maly F. E., Sütsch G., Roffi M., Neidhart M., Eberli F. R., Tanner F. C., Gobbi S., von Eckardstein A., Lüscher T. F., Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005 111 11 1355 1361 2-s2.0-20144381067 10.1161/01.CIR.0000158479.58589.0A (Pubitemid 40396800)
24. Aggarwal A., Schneider D. J., Terrien E. F., Sobel B. E., Dauerman H. L., Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. The American Journal of Cardiology 2004 93 1 6 9 2-s2.0-0347694641 10.1016/j.amjcard.2003.09.003 (Pubitemid 38022025)
25. Inoue T., Kato T., Uchida T., Sakuma M., Nakajima A., Shibazaki M., Imoto Y., Saito M., Hashimoto S., Hikichi Y., Node K., Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. Journal of the American College of Cardiology 2005 46 2 239 245 2-s2.0-22044446512 10.1016/j.jacc.2005.04.029 (Pubitemid 40966850)
26. Ko Y.-G., Jung J.-H., Park S., Choi E., Joung B., Hwang K.-C., Ha J.-W., Choi D., Jang Y., Chung N., Shim W.-H., Cho S.-Y., Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction. International Journal of Cardiology 2006 112 1 66 71 2-s2.0-33747329902 10.1016/j.ijcard.2005.10.005 (Pubitemid 44247179)
27. Taylor S. L., Renshaw B. R., Garka K. E., Smith D. E., Sims J. E., Genomic organization of the interleukin-1 locus. Genomics 2002 79 5 726 733 2-s2.0-0036257305 10.1006/geno.2002.6752 (Pubitemid 34499489)
28. Grainger D. J., Kemp P. R., Metcalfe J. C., Liu A. C., Lawn R. M., Williams N. R., Grace A. A., Schofield P. M., Chauhan A., The serum concentration of active transforming growth factor- β is severely depressed in advanced atherosclerosis. Nature Medicine 1995 1 1 74 79 2-s2.0-0028918825 10.1038/nm0195-74
29. Robertson A.-K., Hansson G. K., T cells in atherogenesis: for better or for worse? Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 11 2421 2432 2-s2.0-33750203252 10.1161/01.ATV.0000245830.29764.84 (Pubitemid 44607461)
30. Gautier E. L., Huby T., Saint-Charles F., Ouzilleau B., Pirault J., Deswaerte V., Ginhoux F., Miller E. R., Witztum J. L., Chapman M. J., Lesnik P., Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 2009 119 17 2367 2375 2-s2.0-66349115961 10.1161/CIRCULATIONAHA.108.807537
31. Methe H., Brunner S., Wiegand D., Nabauer M., Koglin J., Edelman E. R., Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. Journal of the American College of Cardiology 2005 45 12 1939 1945 2-s2.0-20444458026 10.1016/j.jacc.2005.03.040 (Pubitemid 40814112)
32. Eid R. E., Rao D. A., Zhou J., Lo S.-F., Ranjbaran H., Gallo A., Sokol S. I., Pfau S., Pober J. S., Tellides G., Interleukin-17 and interferon- γ are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009 119 10 1424 1432 2-s2.0-64549126102 10.1161/CIRCULATIONAHA.108.827618
33. Hermansson A., Johansson D. K., Ketelhuth D. F. J., Andersson J., Zhou X., Hansson G. K., Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 2011 123 10 1083 1091 2-s2.0-79953037006 10.1161/CIRCULATIONAHA.110. 973222
34. -/- mice. Journal of the American Heart Association 2013 2 5 e000391 10.1161/JAHA.113.000391
35. Mallat Z., Corbaz A., Scoazec A., Besnard S., Lesèche G., Chvatchko Y., Tedgui A., Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001 104 14 1598 1603 2-s2.0-0035797867 10.1161/hc3901.096721 (Pubitemid 32947520)
36. Elhage R., Jawien J., Rudling M., Ljunggren H.-G., Takeda K., Akira S., Bayard F., Hansson G. K., Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovascular Research 2003 59 1 234 240 2-s2.0-0038094522 10.1016/S0008-6363(03)00343-2 (Pubitemid 36776389)
37. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., Humbert Y., Chvatchko Y., Tedgui A., Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circulation Research 2001 89 7 E41 E45 2-s2.0-2942551762 10.1161/hh1901.098735
38. Puren A. J., Fantuzzi G., Gu Y., Su M. S., Dinarello C. A., Interleukin-18 (IFN γ -inducing factor) induces IL-8 and IL-1 β via TNF α production from non-CD14+ human blood mononuclear cells. The Journal of Clinical Investigation 1998 101 3 711 721 2-s2.0-0031987322 10.1172/JCI1379 (Pubitemid 28084257)
39. Kelly R. A., Smith T. W., Cytokines and cardiac contractile function. Circulation 1997 95 4 778 781 2-s2.0-0031058388 10.1161/01.CIR.95.4.778 (Pubitemid 27091510)
40. Krown K. A., Page M. T., Nguyen C., Zechner D., Gutierrez V., Comstock K. L., Glembotski C. C., Quintana P. J. E., Sabbadini R. A., Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. The Journal of Clinical Investigation 1996 98 12 2854 2865 2-s2.0-0030453430 10.1172/JCI119114
41. Koglin J., Granville D. J., Glysing-Jensen T., Mudgett J. S., Carthy C. M., McManus B. M., Russell M. E., Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation 1999 99 6 836 842 2-s2.0-0032931313 10.1161/01.CIR.99.6.836 (Pubitemid 29083027)
42. Jeremias I., Kupatt C., Martin-Villalba A., Habazettl H., Schenkel J., Boekstegers P., Debatin K.-M., Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 2000 102 8 915 920 2-s2.0-0034702911 10.1161/01.CIR.102.8.915
43. Felzen B., Shilkrut M., Less H., Sarapov I., Maor G., Coleman R., Robinson R. B., Berke G., Binah O., Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: a major role for inositol 1,4,5-trisphosphate. Circulation Research 1998 82 4 438 450 2-s2.0-0032498789 10.1161/01.RES.82.4.438 (Pubitemid 28117325)
44. Hartford M., Wiklund O., Hultén L. M., Persson A., Karlsson T., Herlitz J., Hulthe J., Caidahl K., Interleukin-18 as a predictor of future events in patients with acute coronary syndromes. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 10 2039 2046 2-s2.0-77957697859 10.1161/ATVBAHA.109.202697
45. Banda N. K., Vondracek A., Kraus D., Dinarello C. A., Kim S.-H., Bendele A., Senaldi G., Arend W. P., Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. The Journal of Immunology 2003 170 4 2100 2105 2-s2.0-0037442112 (Pubitemid 36197432)
46. Bufler P., Azam T., Gamboni-Robertson F., Reznikov L. L., Kumar S., Dinarello C. A., Kim S.-H., A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13723 13728 2-s2.0-0037109051 10.1073/pnas.212519099 (Pubitemid 35215448)